DyDo Group Holdings

DyDo Group Holdings is a Japan-based publicly traded holding company whose core businesses are nonalcoholic beverages, food, and healthcare-related operations. The group is best known for its domestic beverage vending and soft drink business, but it also owns pharmaceutical-related subsidiaries including DAIDO Pharmaceutical Corporation and orphan-drug subsidiary DyDo Pharma. Through DyDo Pharma, the group in-licenses and develops rare-disease medicines for the Japanese market, including Firdapse for Lambert-Eaton myasthenic syndrome and an LCAT-related program for familial LCAT deficiency. DAIDO Pharmaceutical also manufactures drinkable preparations, quasi-medicines, and related products. Overall, DyDo Group Holdings is a diversified consumer and healthcare-adjacent commercial group rather than a pure-play biotech or pharma company.